Pnc Financial Services Group, Inc. Relmada Therapeutics, Inc. Transaction History

Pnc Financial Services Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$2.22 - $3.54 $3,911 - $6,237	-1,762 Reduced 94.73%	98 $0
Q1 2023 May 15, 2023	BUY	$2.24 - $4.76 $3,552 - $7,549	1,586 Added 578.83%	1,860 $4,000
Q4 2022 Feb 10, 2023	BUY	$2.17 - $35.84 $427 - $7,060	197 Added 255.84%	274 $0
Q3 2022 Nov 10, 2022	BUY	$18.3 - $37.02 $1,171 - $2,369	64 Added 492.31%	77 $2,000
Q1 2022 May 12, 2022	BUY	$16.72 - $26.99 $217 - $350	13 New	13 $0

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $11.7M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.